Recent advances in the pharmacological management of migraine
Open Access
- 8 May 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (39)
- https://doi.org/10.3410/m1-39
Abstract
Recent advances in the pharmacological management of migraineThis publication has 19 references indexed in Scilit:
- CGRP-receptor antagonism in migraine treatmentThe Lancet, 2009
- Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trialThe Lancet, 2008
- Excessive acute migraine medication use and migraine progressionNeurology, 2008
- Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineNeurology, 2008
- Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of AlmotriptanCephalalgia, 2008
- European principles of management of common headache disorders in primary care.2007
- Sumatriptan-Naproxen for Acute Treatment of MigraineJAMA, 2007
- EFNS guideline on the drug treatment of migraine – report of an EFNS task forceEuropean Journal of Neurology, 2006
- Review of clinical trials using early acute intervention with oral triptans for migraine managementInternational Journal of Clinical Practice, 2006
- Should We Advise Patients to Treat Migraine Attacks Early?Cephalalgia, 2004